Mycobacterium tuberculosis inducing disseminated intravascular coagulation

被引:29
作者
Wang, JY
Hsueh, PR
Lee, LN
Liaw, YS
Shau, WY
Yang, PC
Luh, KT
机构
[1] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
关键词
tuberculosis; disseminated intravascular coagulation; acute respiratory distress syndrome; hemophagocytosis; early treatment;
D O I
10.1160/TH04-09-0562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disseminated intravascular coagulation (DIC) can develop infrequently in patients with tuberculosis and has a very high mortality rate. We conducted a retrospective study to evaluate the incidence of tuberculosis-induced DIC and to investigate the clinical manifestation, outcome, and prognostic factors of such patients. From January 2002 to December 2003, all culture-proven tuberculosis patients who developed DIC before starting anti-tuberculosis treatments were selected for this study. Patients who had other clinical conditions or were infected by other pathogens that may have been responsible for their DIC were excluded. Survival analysis was performed for each variable with possible prognostic significance. Our results showed that 27 (3.2%) out of the 833 patients with culture-proven tuberculosis had tuberculosis-induced DIC with a mortality rate of 63.0%. The most common clinical manifestations were fever (63.0%) and multiple patches of pulmonary consolidation (59.3%). Seven (25.9%) patients had disseminated tuberculosis. Twelve (44.4%) developed acute respiratory distress syndrome and three (11.1%) were associated with hemophagocytosis. Twenty-four (88.9%) patients had findings that were unusual for an acute bacterial infection,such as positive acid-fast smear, miliary pulmonary lesions, lymphocytotic exudative pleural effusion, and mediastinal lymphadenopathy. Early anti-tuberculosis treatment significantly improved survival. In conclusion, tuberculosis can cause DIC. Patients with non-miliary, non-disseminated tuberculosis could also develop the rare clinical manifestation. Since the prognosis was very poor in patients not treated at an early stage, a high index of suspicion is required, especially in those with clinical findings suggestive of tuberculosis.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 50 条
[41]   Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH) [J].
Taylor, FB ;
Toh, CH ;
Hoots, WK ;
Wada, H ;
Levi, M .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) :1327-1330
[42]   CYTOKINES AND TUBERCULOSIS [J].
WALLIS, RS ;
ELLNER, JJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (05) :676-681
[43]   Tuberculous myositis: a rare but existing clinical entity [J].
Wang, JY ;
Lee, LN ;
Hsueh, PR ;
Shih, JY ;
Chang, YL ;
Yang, PC ;
Luh, KT .
RHEUMATOLOGY, 2003, 42 (07) :836-840
[44]   Medical progress - The acute respiratory distress syndrome. [J].
Ware, LB ;
Matthay, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1334-1349
[45]   HISTIOCYTIC HEMOPHAGOCYTOSIS IN MILIARY TUBERCULOSIS [J].
WEINTRAUB, M ;
SIEGMANIGRA, Y ;
JOSIPHOV, J ;
RAHMANI, R ;
LIRON, M .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (10) :2055-2056
[46]  
*WHO, 1996, GROUPS RISK WHO REPO
[47]   Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient: Case report and review of the literature [J].
Yang, CW ;
Lee, JH ;
Kim, YG ;
Kim, YO ;
Lee, SH ;
Kim, BK ;
Bang, BK .
NEPHRON, 1996, 72 (04) :690-692
[48]  
YU YL, 1986, Q J MED, V59, P421
[49]  
Zhang Jie, 2004, Tenn Med, V97, P164
[50]  
1995, N ENGL J MED, V333, P341